The clinical characteristics of patients with hip fractures in typical locations and atypical femoral fractures

被引:9
|
作者
Velasco, Soledad [1 ]
Kim, Sandra [2 ]
Bleakney, Robert [3 ]
Jamal, Sophie A. [2 ,4 ]
机构
[1] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Unidad Endocrinol, Santiago, Chile
[2] Univ Toronto, Womens Coll Hosp, Div Endocrinol & Metab, Toronto, ON, Canada
[3] Univ Toronto, Mt Sinai Hosp, Dept Med Imaging, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada
关键词
Atypical fracture; Atypical femoral fracture; Bisphosphonate; BISPHOSPHONATE USE; FEMUR FRACTURES; SHAFT FRACTURES; ALENDRONATE; RISK; WOMEN;
D O I
10.1007/s11657-014-0171-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A Summary The pathophysiology of atypical fractures is unknown. We compared characteristics of patients with atypical femoral fractures and hip fractures in typical locations of the femur. Patients with atypical fracture reported a longer duration of use of bisphosphonates, had higher body mass index, and higher total hip bone mineral density. Further studies are needed. Introduction This study aims to describe the characteristics of patients with typical and atypical fractures of the femur assessed in a tertiary care osteoporosis center. Methods We abstracted clinical, laboratory, and radiographic data on subjects with a history of a low-impact fracture at the femur and/or hip (confirmed by review of radiograph and/or radiology report) from January 2008 to October 2011. Available radiographs were reviewed and fracture categorized as typical or atypical by a radiologist blinded to the original diagnosis. Results Radiology reports were available for 72 subjects: 40 hip fractures in typical locations (typical fracture), 16 atypical femoral fracture (atypical fracture), and 16 were excluded. While both those with typical and atypical fractures reported taking bisphosphonates at the time of fracture, duration of use was longer with atypical fractures (104.2 +/- 42.0 months) compared with typical (71.1 +/- 62.8 months) (p=0.04). Body mass index (BMI) was higher in patients with atypical fractures (26.2 +/- 3.2 kg/m(2)) than in those with typical (23.1 +/- 4.3 kg/m(2)) (p=0.006). Total bone mineral density (BMD) was higher in patients with atypical fracture (0.795 +/- 0.102) versus typical (0.686 +/- 0.130) (p=0.003) Previous history of cancer was reported by 7 of 16 patients with atypical and 7 of 40 patients with typical fracture (p=0.04). Conclusions Compared to those with typical fractures, patients with atypical fracture report a longer duration of use of bisphosphonates, higher BMI, and higher total hip BMD. Future studies should examine if these differences contribute to the pathophysiology of atypical fractures.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Atypical periprosthetic femoral fractures of the hip: A PRISMA compliant systematic review
    De Cicco, Annalisa
    Toro, Giuseppe
    Oliva, Francesco
    Tarantino, Umberto
    Panni, Alfredo Schiavone
    Maffulli, Nicola
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2021, 52 (08): : 2407 - 2414
  • [32] Atypical femoral fractures
    Lee, Paul
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (04) : 384 - 385
  • [33] Atypical femoral fractures
    Butler, I
    Tipping, B.
    Bhaga, R.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2013, 18 (02) : 125 - 127
  • [34] Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series
    Bogl, H. P.
    Aspenberg, P.
    Schilcher, J.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (08) : 2439 - 2444
  • [35] Association of Atypical Femoral Fractures with Bisphosphonate Use by Patients with Varus Hip Geometry
    Hagen, Jennifer E.
    Miller, Anna N.
    Ott, Susan M.
    Gardner, Michael
    Morshed, Saam
    Jeray, Kyle
    Alton, Timothy B.
    Ren, Dennis
    Abblitt, W. Parker
    Krieg, James C.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2014, 96A (22) : 1905 - 1909
  • [36] Current concepts in the management of bisphosphonate associated atypical femoral fractures
    Rudran, Branavan
    Super, Jonathan
    Jandoo, Rajan
    Babu, Victor
    Nathan, Soosai
    Ibrahim, Edward
    Wiik, Anatole Vilhelm
    WORLD JOURNAL OF ORTHOPEDICS, 2021, 12 (09): : 660 - 671
  • [37] The incidence of and risk factors for developing atypical femoral fractures in Japan
    Saita, Yoshitomo
    Ishijima, Muneaki
    Mogami, Atsuhiko
    Kubota, Mitsuaki
    Baba, Tomonori
    Kaketa, Takefumi
    Nagao, Masashi
    Sakamoto, Yuko
    Sakai, Kensuke
    Homma, Yasuhiro
    Kato, Rui
    Nagura, Nana
    Miyagawa, Kei
    Wada, Tomoki
    Liu, Lizu
    Matsuoka, Joe
    Obayashi, Osamu
    Shitoto, Katsuo
    Nozawa, Masahiko
    Kajihara, Hajime
    Gen, Hogaku
    Kaneko, Kazuo
    JOURNAL OF BONE AND MINERAL METABOLISM, 2015, 33 (03) : 311 - 318
  • [38] Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures
    Phillips, H. K.
    Harrison, S. J.
    Akrawi, H.
    Sidhom, S. A.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2017, 48 (06): : 1159 - 1164
  • [39] A rare case of bilateral proximal femoral insufficiency fractures after interlocking IM nailing for bilateral atypical femoral shaft fractures
    Kim, Young Sung
    Chung, Phil Hyun
    Kang, Suk
    Kim, Jong Pil
    Lee, Ho Min
    Moon, Han Sol
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2015, 135 (09) : 1227 - 1232
  • [40] The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs)
    Makkar, Binni
    Obremskey, William
    Avidano, Ryan
    Ott, Susan
    Basida, Brinda
    Hoffer, Colton
    Schousboe, John T.
    Lo, Joan
    Huling, Jared
    Ristau, Kim
    Fink, Howard A.
    Adler, Robert A.
    Barzilay, Joshua I.
    Carbone, Laura
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (03) : 539 - 546